Evonik Industries
Tracked across 4 events · 29 articles · First seen Jul 08, 2026 · Last active Sep 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Evonik is the investing company; the $100M upgrade enhances its U.S. drug substance manufacturing capabilities, supporting long-term growth and asset balancing.
Jul 08, 2026 · 9 articles
Business
Impact: Evonik is the primary investor, committing over 150 million CAD to expand its lipid-based drug delivery manufacturing capacity in Vancouver, strengthening its position in the growing LNP market.
Aug 27, 2026 · 8 articles
Business
Impact: Evonik raised its full-year profit guidance, reflecting benefits from Middle East conflict-related supply disruptions.
Jul 20, 2026 · 6 articles
Business
CordenPharma, a global pharmaceutical contract development and manufacturing organization (CDMO) backed by private equity firm Astorg, announced the appointment of Dr. Jean-Luc Herbeaux as Chief Executive Officer effective 1 October 2026. Herbeaux succeeds Dr. Michael…
Impact: Evonik is mentioned only as a former employer where Herbeaux held senior roles before joining Hovione. It has no direct operational role in the transition.
Sep 15, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Evonik Industries live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard